VH 032 amide-alkylC3-acid is primarily utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). This compound serves as a key ligand that binds to E3 ubiquitin ligases, facilitating the recruitment of specific proteins for ubiquitination and subsequent degradation by the proteasome. Its application is significant in drug discovery and therapeutic research, especially for diseases caused by malfunctioning or overexpressed proteins, such as cancer, neurodegenerative disorders, and autoimmune conditions. The compound’s structure allows for precise targeting and degradation of disease-related proteins, offering a promising approach for developing novel treatments.